Sunderland Nicholas, Nagendran Myura, Maruthappu Mahiben
St Hugh's College, University of Oxford, St Margaret's Road, Oxford OX2 6LE, UK.
Interact Cardiovasc Thorac Surg. 2011 Dec;13(6):635-41. doi: 10.1510/icvts.2011.275511. Epub 2011 Sep 1.
A best evidence topic in cardiothoracic surgery was written according to a structured protocol. The question addressed was: In [adults undergoing a maze procedure for atrial fibrillation (AF)], [does left atrial size reduction] compared to [maze surgery alone] improve [maze surgery success]? A total of 58 papers were found using the reported search, of which eight represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. Four out of eight papers compared a volume reduction technique as an adjunct to the maze procedure to a maze procedure alone--all four papers reported that atrial volume reduction significantly increased restoration of sinus rhythm: 89.3% vs. 67.2%, P<0.001; 85% vs. 68%, P<0.05; 84% vs. 68%, P<0.05; 90% vs. 69%, P<0.05. Three out of eight papers had no control group but reported good rates of sinus rhythm restoration at last follow-up--90%, 92% and 89%, respectively--despite the study population including atrial enlargement, a risk factor for failure of a maze procedure. One paper reported no benefit of an atrial reduction plasty in patients with a left atrium (LA) >70 mm. An enlarged LA is a risk factor for failure of a maze procedure, and various models of AF suggest that reducing atrial mass and/or diameter may help to abolish the re-entry circuits underlying AF. Furthermore, AF is uncommon when left atrial diameter is <40 mm, so there is at least some physiological basis for atrial reduction surgery in aiding the success of a maze procedure. The evidence suggests that patients with an enlarged (≥ 55 mm) or giant (≥ 75 mm) LA who are at risk of failing to obtain sinus conversion after a standard maze procedure may derive benefit from concomitant atrial reduction surgery using either a tissue excision or a tissue plication technique. However, the evidence is not strong since the papers available are not readily comparable owing to substantial variations in the populations and procedures involved. We therefore, emphasise the need for prospective randomised studies in this area.
根据结构化方案撰写了一篇心胸外科最佳证据主题文章。探讨的问题是:在[接受迷宫手术治疗心房颤动(AF)的成年人]中,与[单纯迷宫手术]相比,[左心房尺寸减小]是否能提高[迷宫手术成功率]?通过报告的检索共找到58篇论文,其中8篇代表回答该临床问题的最佳证据。现将这些论文的作者、期刊、出版日期和国家、研究的患者组、研究类型、相关结局和结果制成表格。8篇论文中有4篇将容积减小技术作为迷宫手术的辅助手段与单纯迷宫手术进行了比较——所有4篇论文均报告心房容积减小显著提高了窦性心律恢复率:89.3%对67.2%,P<0.001;85%对68%,P<0.05;84%对68%,P<0.05;90%对69%,P<0.05。8篇论文中有3篇没有对照组,但报告了最后随访时良好的窦性心律恢复率——分别为90%、92%和89%——尽管研究人群包括心房扩大,这是迷宫手术失败的一个危险因素。一篇论文报告称,左心房(LA)>70 mm的患者进行心房减容成形术没有益处。LA增大是迷宫手术失败的一个危险因素,各种房颤模型表明,减小心房质量和/或直径可能有助于消除房颤潜在的折返环路。此外,当左心房直径<40 mm时,房颤并不常见,因此心房减容手术在辅助迷宫手术成功方面至少有一些生理基础。证据表明,标准迷宫手术后有窦性心律转复失败风险的LA增大(≥55 mm)或巨大(≥75 mm)的患者,可能从使用组织切除或组织折叠技术的同期心房减容手术中获益。然而,证据并不充分,因为由于所涉及的人群和手术存在很大差异,现有论文难以直接比较。因此,我们强调该领域需要进行前瞻性随机研究。